Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — injecting Wegovy into the same spot week after week is not recommended. The Wegovy Patient Information Leaflet and clinical guidance both advise rotating your injection site each time you dose. Using the same spot repeatedly can cause lumps, hardened tissue or skin changes that affect how well the medicine is absorbed. This page explains why rotation matters, how to do it properly, and what to watch for if you've already noticed a reaction at a previous site. Like all prescription-only weight management treatments, Wegovy requires clinical assessment before you start, and your prescriber can talk you through good injection technique at that point.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Beneath the skin sits a layer of fatty (subcutaneous) tissue. When the same small area receives repeated injections, the body's local response can cause that tissue to thicken and harden, a condition called lipohypertrophy. It looks and feels like a rubbery lump under the skin, and it is not just a cosmetic nuisance.
The problem is absorption. Semaglutide, the active ingredient in Wegovy, needs to pass from the subcutaneous layer into your bloodstream at a consistent rate. Hardened tissue is less vascular and less receptive, so the medicine may be absorbed more slowly or unevenly. That inconsistency can mean the dose you inject is not the dose your body actually receives, something that matters particularly during the titration phase, when the prescriber is adjusting your treatment based on how you respond.
The NHS patient information for semaglutide highlights skin reactions and injection-site changes as things to monitor. The Wegovy SmPC, available on the eMC, is the definitive technical reference for how to administer each dose correctly. If you are curious about what a Wegovy injection site reaction looks like and when it warrants further advice, that page covers the detail.
There are three licensed sites: the abdomen (avoiding a 5 cm radius around your navel), the front or outer thigh, and the back of the upper arm. You can use any of these for each weekly injection, and you do not have to return to the same body part every time.
A practical approach many people find helpful is to divide each site into zones mentally (think of the abdomen as a clock face, moving one position clockwise each week) so that no single spot receives two consecutive injections. Some people keep a simple log in their phone or on a piece of paper tucked in with their pens in the fridge. It takes seconds and removes any guesswork.
If you share the injection between left and right sides of the body as well as moving around within each site, you give each area roughly a month to recover before it is used again. The guidance on finding your best Wegovy injection site goes into more practical detail about positioning, including tips on choosing the most comfortable location for each dose, and our page on all the sites you can use for Wegovy covers each location in full. The short answer here: spread the injections out and keep a loose mental map.
The licensed sites (abdomen, thigh, upper arm) show broadly similar absorption profiles in clinical pharmacology data, so switching between them week to week should not introduce meaningful variability in drug levels. What does introduce variability is injecting into tissue that has been damaged by overuse. That is the scenario rotation is designed to prevent.
In the STEP 1 trial, which followed nearly 2,000 adults taking semaglutide 2.4 mg over 68 weeks and was published in the New England Journal of Medicine, participants achieved around 15% average body-weight reduction. That result depends on reliable dose delivery, which, in turn, depends partly on healthy injection sites. Good technique is part of what makes the medicine perform as it did in the trial.
Worth knowing: if you are switching from one site to another because an area is sore or lumpy, that is exactly the right instinct, and our page on the best spot to inject Wegovy can help you choose a fresh location with confidence. You can read more about how Wegovy compares to other once-weekly treatments on the Wegovy overview page.
If you have noticed a lump, firmness or discolouration where you have been injecting, rest that area. Avoid it for several weeks and use a fresh site in the meantime. Lipohypertrophy can resolve on its own once repeated trauma stops, though it may take time.
If the lump is large, growing, painful, hot to the touch, or showing signs of infection (increasing redness, swelling, warmth) speak to a healthcare professional promptly rather than waiting. Minor redness or itching that settles within a few days after injection is common and not usually a concern, but anything persistent or getting worse deserves attention, and our page on what happens if you inject Wegovy in the wrong spot explains the specific risks in more detail. You can reach the nume clinical team through our contact page if you have a specific question about a site reaction.
One thing our prescribers are asked fairly regularly: does it help to use a new needle for each injection? Yes. Needles blunt quickly, and a fresh needle causes less tissue trauma at the injection site. Using replacement pen needles each time is standard advice in injection technique guidance and reduces both discomfort and the risk of site changes over time.
If you have not yet started treatment and want advice on technique before your first dose, speaking to our prescribers is the right next step. They can answer questions about injection practice as part of your consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.